Treatment of Anxiety in Stabilized Bipolar Disorder

Introduction to Anxiolytic Agents

The American Academy of Child and Adolescent Psychiatry recommends lamotrigine as the first-line anxiolytic agent for patients with stabilized bipolar disorder on lithium and lurasidone, due to its mood stabilization properties and efficacy in preventing depressive episodes while addressing comorbid anxiety without risking mood destabilization 1, 2

Lamotrigine is the optimal choice because it serves dual purposes—maintaining mood stability while providing anxiolytic effects—and is specifically recommended by the American Academy of Child and Adolescent Psychiatry for maintenance therapy in bipolar disorder, particularly when depressive symptoms or anxiety predominate 1, 2
The American Academy of Child and Adolescent Psychiatry recommends lamotrigine due to its efficacy in preventing depressive episodes, which often co-occur with anxiety in bipolar disorder 2

Lamotrigine does not cause sedation or significant weight gain, addressing common tolerability concerns with other mood stabilizers 1
Lamotrigine is particularly effective for preventing depressive episodes, which often co-occur with anxiety in bipolar disorder 2
Lamotrigine can be safely combined with lithium and lurasidone without significant drug interactions 1
Lamotrigine provides anxiolytic effects through mood stabilization rather than requiring separate anxiety-specific medications 3

Lamotrigine must be titrated slowly to minimize the risk of Stevens-Johnson syndrome—start at 25mg daily for 2 weeks, then 50mg daily for 2 weeks, then increase by 50mg every 1-2 weeks to target dose of 200mg daily 1
If lamotrigine is discontinued for more than 5 days, restart with the full titration schedule rather than resuming the previous dose 1

Anticonvulsants used as mood stabilizers, particularly pregabalin or gabapentin, may provide anxiolytic effects without risking mood destabilization 1
Gabapentin: start 300mg at bedtime, titrate to 900-1800mg daily in divided doses 4
Pregabalin: start 75mg twice daily, titrate to 150-300mg twice daily 4
Both require dose reduction in renal insufficiency and can cause dose-dependent dizziness and sedation 4

If anxiety remains severe despite mood stabilizer optimization, an SSRI may be added, but ONLY in combination with adequate mood stabilization (lithium plus lurasidone already provides this) 3
Fluoxetine is preferred as it has FDA approval in combination with olanzapine for bipolar depression 3
SSRIs carry significant risks in bipolar disorder: mood destabilization, mania induction, rapid cycling, behavioral activation, and suicidal thinking (particularly in younger patients) 1
Monitor closely for signs of mood destabilization including increased energy, decreased sleep need, impulsivity, or irritability 1

Benzodiazepines should be reserved for acute, short-term use only: may be used PRN for severe acute anxiety (lorazepam 0.25-0.5mg, maximum 2mg daily, not more than 2-3 times weekly) 1
Benzodiazepines carry risks of tolerance, dependence, paradoxical agitation (10% of patients), and four-fold increased overdose risk when combined with other CNS depressants 1
Abrupt withdrawal can cause seizures, delirium, and rarely death—if discontinuation is needed, taper by 25% every 1-2 weeks 1
Cognitive behavioral therapy increases tapering success rates and should be offered if benzodiazepine discontinuation is attempted 1

Educate patient about rash recognition—any rash requires immediate discontinuation and evaluation 1
Monitor for mood symptoms at 2-week intervals during titration 1
Assess anxiety symptoms using standardized measures at 4 and 8 weeks 1
Maintain existing monitoring for lithium and lurasidone: lithium levels, renal and thyroid function every 3-6 months 1
BMI monthly for 3 months then quarterly; blood pressure, fasting glucose, and lipids at 3 months then yearly for lurasidone 1

Cognitive behavioral therapy should be offered as an adjunctive non-pharmacological approach for anxiety management, as it has strong evidence for both anxiety and depression components of bipolar disorder and may reduce the need for additional medications 1, 3

First: Add lamotrigine with slow titration (25mg→50mg→100mg→200mg over 6-8 weeks) 1, 2
If lamotrigine contraindicated or ineffective after 8 weeks: Add gabapentin or pregabalin 1
If anxiety remains severe despite above: Consider adding SSRI (fluoxetine preferred) with close monitoring for mood destabilization 3
Reserve benzodiazepines for acute, PRN use only (lorazepam 0.25-0.5mg, maximum 2-3 times weekly) 1
Integrate CBT throughout to address anxiety symptoms and potentially reduce medication burden 1, 3